Stocks and Investing
Stocks and Investing
Fri, April 29, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (AMGN) at Hold with Increased Target to $223 on, Apr 28th, 2022
Gregory Renza of RBC Capital, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $218 to $223 on, Apr 28th, 2022.
Gregory has made no other calls on AMGN in the last 4 months.
There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 4 agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $236 on, Tuesday, April 12th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $237 on, Tuesday, April 12th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $250 on, Wednesday, February 9th, 2022
- Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $255 on, Wednesday, January 5th, 2022
This is the rating of the analyst that currently disagrees with Gregory
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $285 on, Wednesday, February 9th, 2022
Contributing Sources